Scientists see new vocal patterns associated with type 2 diabetes

A new study in the IEEE Journal of Biomedical and Health Informatics reveals how scientists at Klick Labs created visual maps ...
ainvest

TC Energy Finalizes Indigenous Investment Plan for Coastal GasLink

TC Energy's finalized investment agreement reinforces the importance of Indigenous participation as Canada's energy ...
PR Newswire

Johnson & Johnson announces new data showing TREMFYA® (guselkumab) is the only IL-23 to deliver durable fistula remission through 48 weeks in Crohn's disease …

Johnson & Johnson (NYSE: JNJ) today announced one-year results from the Phase 3 FUZION study showing TREMFYA® (guselkumab) ...

Johnson & Johnson announces new TREMFYA® (guselkumab) data showing durable 3-year outcomes in moderate to severe Crohn’s disease and expanding evidence in perianal fistula

New TREMFYA® (guselkumab) 3-year as-observed data show clinical remission rates of up to 94% (172/183 patients) and endoscopic remission rates of up to 52% (89/172 patients) in adults with moderate to ...

Part 2: Can Micron Retain Profitability Even if Memory Prices Fall?

I view the recent decline in Micron's stock price as a buying opportunity for the medium to long term. In addition to the ...